IMed will continue to partner with TheHill’s flagship NHS Market Access Accelerator (MAA) into 2025/2026, following the extension of a successful partnership agreement.
IMed offer a range of expert services to the global medical and health technology industry and delivered sessions to our 2024 cohort on medical device regulations, something which they will continue to deliver for the upcoming cohort, along with one-to-one surgeries for cohort members to discuss their regulatory pathway.
“We’re proud to continue our partnership with TheHill and support another cohort of innovative companies through the NHS Market Access Accelerator,”said Jonathan Ripley, Managing Director at IMed Consultancy. “Understanding and navigating medical device regulation is a critical step for start-ups looking to bring their technologies to market, and we’re committed to providing founders our expertise to build the confidence and capability they need to bring their innovation to market.”
Rowan Mould, Start-Up Accelerator manager added: “We’re thrilled to have IMed Consultancy on board as a partner for the MAA in 2025. A thorough understanding of the regulatory landscape and how to navigate it is essential for our founders and IMed’s wealth of knowledge and experience in the field have been a vital resource for our cohorts to call on as they move forward in their journey. I’m excited to be working alongside the IMed team again this year.”
TheHill’s 2025 MAA programme has begun, with sessions being delivered in-person and online. Companies on the programme will be announced via our LinkedIn throughout June and on our website.